SRPT : Analysis & Opinions

  1. The Market In 5 Minutes: We're Gathered Here To Get Through This ...

    June 7, 2016
    Below is a tool used by the Benzinga News Desk each trading day -- it's a look at everything happening in the market, in ...
  2. Biotech Stocks: Are They Back?

    June 1, 2016
    The bearish trends over the past year have started to reverse themselves which has benefted the biotech industry
  3. Sarepta Therapeutics One Step Closer to Drug Approval

    July 3, 2015
    Analysts are optimistic about the future of Sarepta as the biotechnology company submits a New Drug Application the FDA.
  4. Sarepta Gets FDA Green Light to Submit Application (SRPT, BMRN)

    May 20, 2015
    It's not often you see a biotech soar more than 60% after announcing plans to submit a marketing application to the Food ...
  5. Sarepta Earnings Preview: 3 Things to Watch For (SRPT)

    May 4, 2015
    Since the stock peaked at more than $55 per share in October 2013, Sarepta Therapeutics' (NASDAQ: SRPT) shareholders have ...
  6. Sarepta Therapeutics' 3 Biggest Risks (SRPT)

    March 23, 2015
    There are arguably few diagnoses as frightening for children and their parents as Duchenne muscular dystrophy, or DMD. Based ...
Trading Center